Zoe Jacoby is an associate in the Litigation Department.
Ms. Jacoby joined Debevoise in 2023. Ms. Jacoby received her J.D. from Columbia Law School ...
Read Full Biography
Publications
-
Unpacking President Trump’s New Executive Order on Prescription Drug Pricing
24 April 2025
Andrew L. Bab
, Mark P. Goodman
, Maura Kathleen Monaghan
, Winston M. Paes
, Kevin Rinker
, Paul D. Rubin
, Melissa Runsten
, Jacob W. Stahl
, Abby Draper
, Zoe Jacoby
, Kaitlyn McGill
, Adriana Kranjac Rielly
-
Supreme Court Opens the Door to RICO Claims Arising from Personal Injuries — but with Significant Limitations
8 April 2025
Maura Kathleen Monaghan
, Jacob W. Stahl
, Abby Draper
, Zoe Jacoby
, Kaitlyn McGill
, Allison Miller
, Adriana Kranjac Rielly
-
First Circuit Affirms Causation Defense for False Claims Act Based on AKS Violations
3 March 2025
Maura Kathleen Monaghan
, Winston M. Paes
, Jacob W. Stahl
, Adam Aukland-Peck
, Zoe Jacoby
, Kaitlyn McGill
, Adriana Kranjac Rielly
, Abby Draper
-
Top 10 Healthcare and Life Sciences Issues to Watch in 2025
10 January 2025
Andrew L. Bab
, Tim Cornell
, Avi Gesser
, Mark P. Goodman
, Ted Hassi
, Erez Liebermann
, Maura Kathleen Monaghan
, Kevin Rinker
, Paul D. Rubin
, Michael Schaper
, Jane Shvets
, Patrick Taylor
, Erica S. Weisgerber
, Carter Burwell
, Kim T. Le
, Leah Martin
, Melissa Runsten
, Jacob W. Stahl
, Adam Aukland-Peck
, HJ Brehmer
, Lillian Clark
, Zoe Jacoby
, Adriana Kranjac Rielly
, Chaim Lapp
, Hannah R. Levine
, Kaitlyn McGill
, Adam C. Saunders
, Abby Draper
, Mackenzie Mendolla
-
2024 Private Equity Midyear Outlook
August 2024
Christopher Anthony
, Katherine Ashton
, Dominic Blaxill
, Ezra Borut
, Geoffrey P. Burgess
, Andrew J. Ceresney
, Christopher Dortschy
, Jane Engelhardt
, Andrew Ford
, Mark P. Goodman
, Jyotin Hamid
, Morgan J. Hayes
, Peter J. Irwin
, Eric T. Juergens
, Arian M. June
, Robert B. Kaplan
, M. Natasha Labovitz
, Andrew M. Levine
, Sidney P. Levinson
, Jonathan F. Lewis
, Gregory J. Lyons
, Timothy McIver
, Frank Mitchell
, Maura Kathleen Monaghan
, Edwin Northover
, Brett M. Novick
, Sheena Paul
, Marc Ponchione
, Ryan T. Rafferty
, Julie M. Riewe
, Paul D. Rubin
, Scott B. Selinger
, Thomas Smith
, Kristin A. Snyder
, Rick Sofield
, Katherine Durnan Taylor
, Ramya S. Tiller
, Jonathan R. Tuttle
, Patricia Volhard
, Erica S. Weisgerber
, Jennifer Wheater
, Naomi Aoyama
, Alison E. Buckley-Serfass
, Brett Adam Bush
, Zhiyan Cao
, Jennifer R. Cestaro
, Robert T. Dura
, Paul Eastham
, Stuart Hammer
, Lauren P. Heller
, Jin-Hyuk Jang
, Wen-Wei Lai
, Michael P. McGuigan
, Melissa Runsten
, Tricia Bozyk Sherno
, Jacob W. Stahl
, John Young
, Ulysses Smith
, Kayleigh Anderson
, Hymie A. Anteby
, Jabari Benjamin
, Charles Cartiglia
, Josephine Chen
, Jordan Corrente Beck
, Tejas N. Dave
, Julia Glazer
, Michael C. Godbe
, Zoe Jacoby
, Yiran Ji
, Adriana Kranjac Rielly
, Paul D. Lowry
, Kaitlyn McGill
, Diana Moise
, Amy Pereira
, John M. Satira
, Eike Björn Weidner
, Keith Moshe
-
Law360: After Chevron: FDA Regulations In The Crosshairs
8 July 2024
Law360
Maura Kathleen Monaghan
, Paul D. Rubin
, Jacob W. Stahl
, Zoe Jacoby
, Kaitlyn McGill
-
Chevron Under Fire: What Healthcare and Life Sciences Investors Should Know
19 January 2024
Andrew L. Bab
, Mark P. Goodman
, Maura Kathleen Monaghan
, Kevin Rinker
, Paul D. Rubin
, Melissa Runsten
, Jacob W. Stahl
, Adam Aukland-Peck
, Zoe Jacoby
, Adriana Kranjac Rielly
, Kaitlyn McGill
-
Top 10 Healthcare and Life Sciences Issues to Watch in 2024
4 January 2024
Andrew L. Bab
, Mark P. Goodman
, Ted Hassi
, Maura Kathleen Monaghan
, Kevin Rinker
, Paul D. Rubin
, Michael Schaper
, Erica S. Weisgerber
, Kim T. Le
, Melissa Runsten
, Jacob W. Stahl
, Adam Aukland-Peck
, Ilya Balabanovsky
, Margaret Howard
, Chaim Lapp
, Hannah R. Levine
, Zoe Jacoby
, Kaitlyn McGill
View More Publications